Production of Macrophage Migration Inhibitory Factor by Human and Murine Neuroblastoma

Tumor cells avoid immune recognition by subverting the ability of the immune system to mount an inflammatory response that generates cytotoxic effector cells. This can be achieved through cytokine production by the tumor itself. Our objective was to determine the cytokine profile of neuroblastoma (NB) lesions in tumor vaccine models. We found that the murine NB cell line, Neuro2a, secretes macrophage migration inhibitory factor, MIF, a multifunctional cytokine with the potential to block effective immune responses to a tumor. Patient-derived NB cell lines were also found to produce MIF. MIF production by NB was documented at the level of RNA by RNAse protection, soluble cytokine production by ELISA, and in a macrophage migration assay. Our studies also confirmed reports of IL-6 production by human NB cell lines. NB culture-derived MIF was also shown to activate tumor cell migration. This supports the hypothesis that MIF is a tumor-derived cytokine that may play a role in NB aggressiveness and evasion of immune recognition.

[1]  B. Brennan Principles and Practice of Pediatric Oncology , 2004 .

[2]  R. Bucala,et al.  Regulation of the CTL Response by Macrophage Migration Inhibitory Factor , 2001, The Journal of Immunology.

[3]  J. Bernhagen,et al.  Dissection of the enzymatic and immunologic functions of macrophage migration inhibitory factor. Full immunologic activity of N-terminally truncated mutants. , 2000, European journal of biochemistry.

[4]  J. Bernhagen,et al.  Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1 , 2000, Nature.

[5]  R. Bucala,et al.  Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF). , 2000, Seminars in cancer biology.

[6]  M. Sortino,et al.  Relative Contribution of Different Receptor Subtypes in the Response of Neuroblastoma Cells to Tumor Necrosis Factor‐α , 2000, Journal of neurochemistry.

[7]  P. Mckenna,et al.  Angiogenesis and neuroblastomas: interleukin-8 and interleukin-8 receptor expression in human neuroblastoma. , 2000, The Journal of urology.

[8]  H. Dosaka-akita,et al.  Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung , 2000, Cancer.

[9]  S. Todo,et al.  An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. , 2000, Cytokine.

[10]  S. Onodera,et al.  Macrophage Migration Inhibitory Factor Up-regulates Expression of Matrix Metalloproteinases in Synovial Fibroblasts of Rheumatoid Arthritis* , 2000, The Journal of Biological Chemistry.

[11]  A. Vinik,et al.  Neurotrophic role of interleukin-6 and soluble interleukin-6 receptors in N1E-115 neuroblastoma cells , 2000, Journal of Neuroimmunology.

[12]  R. Abe,et al.  Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts. , 2000, Biochimica et biophysica acta.

[13]  K. Namba,et al.  Different influence of macrophage migration inhibitory factor (MIF) in signal transduction pathway of various T cell subsets. , 2000, Immunobiology.

[14]  G. Hannon,et al.  A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity , 1999, The Journal of experimental medicine.

[15]  M. Suzuki,et al.  High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis. , 1999, Biochemical and biophysical research communications.

[16]  W. Hanlon,et al.  Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration. , 1999, Biochemistry.

[17]  R. Bucala,et al.  An Essential Role for Macrophage Migration Inhibitory Factor (MIF) in Angiogenesis and the Growth of a Murine Lymphoma , 1999, Molecular medicine.

[18]  R. Bucala,et al.  Filarial Nematode Parasites Secrete a Homologue of the Human Cytokine Macrophage Migration Inhibitory Factor , 1998, Infection and Immunity.

[19]  S. Goswami,et al.  Interleukin‐6‐Mediated Autocrine Growth Promotion in Human Glioblastoma Multiforme Cell Line U87MG , 1998, Journal of neurochemistry.

[20]  R. Bucala,et al.  Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Bernhagen,et al.  Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha. , 1998, Journal of immunology.

[22]  G. Wistow,et al.  Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. , 1998, Journal of immunology.

[23]  J. Satoh,et al.  Interleukin-15, a T-cell growth factor, is expressed in human neural cell lines and tissues , 1998, Journal of the Neurological Sciences.

[24]  J. Bernhagen,et al.  Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features , 1998, Journal of Molecular Medicine.

[25]  M. Ziegler,et al.  A comparative review of the immunobiology of murine neuroblastoma and human neuroblastoma , 1997, Cancer.

[26]  J. Bernhagen,et al.  An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction , 1996, The Journal of experimental medicine.

[27]  R. A. Gundorova,et al.  Natural complex of cytokines is a potent stimulant to posttraumatic regeneration in rabbit cornea. , 1996, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[28]  J. Bernhagen,et al.  Localization of Macrophage Migration Inhibitory Factor (MIF) to Secretory Granules within the Corticotrophic and Thyrotrophic Cells of the Pituitary Gland , 1995, Molecular medicine.

[29]  J. Bernhagen,et al.  MIF as a glucocorticoid-induced modulator of cytokine production , 1995, Nature.

[30]  Kazuhito Watanabe,et al.  Interleukin‐12 Augments the Generation of Autologous Tumor‐reactive CD8+ Cytotoxic T Lymphocytes from Tumor‐infiltrating Lymphocytes , 1995, Japanese journal of cancer research : Gann.

[31]  J. Bernhagen,et al.  Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). , 1994, Biochemistry.

[32]  J. Bernhagen,et al.  The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor , 1994, The Journal of experimental medicine.

[33]  R. McIvor,et al.  Interleukin-2 gene transfer into murine neuroblastoma decreases tumorigenicity and enhances systemic immunity causing regression of preestablished retroperitoneal tumors. , 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[34]  K. Tracey,et al.  MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia , 1993, Nature.

[35]  S. Yamamoto,et al.  Distinct cytotoxicity against neuroblastoma cells of peripheral blood and tumor-infiltrating lymphocytes from patients with neuroblastoma. , 1993, Cancer letters.

[36]  E. Coustan-Smith,et al.  Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication. , 1993, British Journal of Cancer.

[37]  D. Cooney,et al.  Combined preoperative and postoperative immunotherapy for murine C1300 neuroblastoma. , 1993, Journal of pediatric surgery.

[38]  R. Truitt,et al.  Immunological evaluation of pediatric cancer patients receiving recombinant interleukin-2 in a phase I trial. , 1992, Journal of immunotherapy : official journal of the Society for Biological Therapy.

[39]  A. Yu,et al.  Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cells. , 1991, Cancer research.

[40]  Q. Myrvik,et al.  Macrophage Migration Inhibition Induced by MDP, LPS, PMA, and MIF/MAF: Reversal by Macrophage Migration Enhancement Factor (MEF), L‐Fucose, L‐Fucosyl BSA, D‐Mannose, and D‐Mannosyl BSA , 1987, Journal of leukocyte biology.